By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sanofi Pasteur 

174, av. de France

Paris    75013  France
Phone: 33-1-53-77-4076 Fax: 33-1-53-77-4174



Company News
Sanofi Pasteur (SASY.PA) Inks $645 Million RSV Deal With AstraZeneca PLC (AZN)'s MedImmune (AZN) 3/3/2017 5:51:43 AM
Sanofi Pasteur (SASY.PA) Announces The Availability of Quadracel DTaP-IPV Vaccine For Children 4 Through 6 Years Of Age In The U.S. 1/31/2017 6:43:35 AM
Sanofi Pasteur (SASY.PA) and Merck & Co. (MRK) Terminate Joint Vaccines Biz in Europe, Effective Immediately 1/3/2017 5:57:00 AM
Sanofi Pasteur (SASY.PA) Abandons Bladder Cancer Drug 11/18/2016 6:18:58 AM
Sanofi Pasteur (SASY.PA) Release: High-Dose Influenza Vaccine With Evidence Of Superior Efficacy* In Older Adults: Now In Canada 10/13/2016 7:35:52 AM
Sanofi Pasteur (SASY.PA) Nabs $43 Million U.S. Funding to Speed Up Zika Vaccine Development 9/27/2016 6:09:07 AM
Dyadic (DYAI) Stock Tanks Amid Reports of Partnership Termination With Sanofi Pasteur (SASY.PA) 8/9/2016 6:46:55 AM
Sanofi Pasteur (SASY.PA) Ships First Of Its 2016-2017 Seasonal Influenza Vaccine Doses In United States 7/26/2016 6:28:12 AM
New Four-Strain Influenza Vaccine, VaxigripTetra, Regulatory Dossier From Sanofi Pasteur (SASY.PA) Now Approved In Europe 6/23/2016 6:21:27 AM
Terrapinn Release: Experts From Merck & Co. (MRK), GlaxoSmithKline (GSK), Pfizer (PFE), Sanofi Pasteur (SASY.PA) And More To Debate Breakthroughs For Vaccines For Ebola, Zika And Cancer. 3/7/2016 10:20:07 AM